Overview

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Status:
Terminated

Trial end date:
2009-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to test the effects of carbidopa/levodopa/entacapone compared to the effects of immediate-release carbidopa/levodopa on non-motor symptoms of end-of-dose wearing off in persons who have Parkinson's disease.

Phase:

Phase 4

Details

Lead Sponsor:

Novartis

Treatments:

Carbidopa
Carbidopa, levodopa drug combination
Entacapone
Levodopa